The drug, Leqembi, is the first that’s been convincingly shown to slow the decline in memory and thinking that defines Alzheimer’s.
also from Biogen and Eisai — was “rife with irregularities,” including a number of meetings with drug company staffers that went undocumented.
Some 6 million people in the U.S. and many more worldwide have Alzheimer’s, which gradually attacks areas of the brain needed for memory, reasoning, communication and daily tasks. There is little consensus on whether that difference translates into real benefits for patients, such as greater independence.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
New Alzheimer’s Drug Approved by FDA, Promises to Slow DiseaseBreaking: A new Alzheimer's drug has been cleared for use in the U.S. Doctors say it could transform the way the disease is treated.
Lire la suite »
FDA Says Retail Pharmacies Can Now Offer Abortion PillsThe U.S. Food and Drug Administration finalized a regulatory change that allows retail pharmacies to offer abortion pills.
Lire la suite »
A New FDA Rule Expands Access to Abortion Pills—Here's What We KnowSoon, abortion pills may be available at your local pharmacy.
Lire la suite »
Sesame officially added to FDA's major food allergen listA new federal law went into effect on Jan. 1 that requires all foods made and sold in the U.S. to be labeled if they contain sesame, which is now the nation's ninth major allergen.
Lire la suite »
More retail pharmacies can now offer abortion pills after FDA rule changeThe Food and Drug Administration on Tuesday finalized a rule change that broadens...
Lire la suite »
FDA Rules That Retail Pharmacies Can Offer Abortion MedicationAbortion bans or restrictions will likely make it illegal to implement the new FDA rule in about half the states.
Lire la suite »